Spider Rock Advisors, LLC Corcept Therapeutics Inc Transaction History
Spider Rock Advisors, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Spider Rock Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 15,000 shares of CORT stock, worth $755,850. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$755,850% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$833 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$504 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$417 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$328 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$192 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.4B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...